Gevorg Yaghjyan/LinkedIn
Apr 9, 2026, 14:46
Gevorg Yaghjyan: Advancing Research and Care for Transketolase Deficiency at Yale
Gevorg Yaghjyan, Project Leader at Parexel, shared a post on LinkedIn:
”New rare-disease research and clinical program has recently been launched at the Yale School of Medicine focusing on Transketolase (TKT) deficiency, an extremely rare genetic metabolic disorder.
The Yale Transketolase Deficiency Program was established to:
- Improve diagnosis of patients with this rare disorder
- Conduct cutting-edge research on the disease mechanism
- Develop future therapeutic strategies
- Provide multidisciplinary clinical care for patients with suspected or confirmed disease
The program is led by physicians and researchers including Andrew Wang and Anna Szekely at Yale.
It collaborates with major rare-disease networks such as:
the Undiagnosed Diseases Network
the National Organization for Rare Disorders (NORD)
to identify additional patients worldwide and accelerate research”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day